Pancreatic Cancer Basics
597 articles
Tough Tortoise of a Drug Beating Metastatic Pancreatic Cancer
Rexahn Pharmaceuticals is testing RX-3117, a slow-releasing drug similar to gemcitabine, in a clinical trial for metastatic pancreatic cancer patients.
Reopening America: Guidelines For Pancreatic Cancer Patients
As states begin to reopen their economies, the threat of COVID-19 remains. Dr. Allyson Ocean has recommendations for pancreatic cancer patients.
Luck, Grit, and Support
Joel Weiss had to travel from his home in Toronto to New York City to get the NanoKnife treatment he wanted for his pancreatic cancer.
Complementary Therapies—a Way to Gain Peace?
What techniques are other pancreatic cancer patients using to relieve symptoms and side effects, and cope with treatment? Learn more about the most popular complementary therapies.
Psychosocial Oncology: Helping Patients Manage Stress During Pancreatic Cancer Treatment
Psychosocial oncology uses the creative arts to help pancreatic cancer patients manage stress during treatment, explains Dr. William Breitbart.
A PARP Inhibitor Approval for Pancreatic Cancer
PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.
Treating High Blood Sugar in People With Pancreatic Cancer
A new clinical trial explores the effectiveness of the drug glipizide in controlling high blood sugar in pancreatic cancer patients.
Blood-Based Test Predicts What Drugs May Work Best
Dr. Kenneth Yu is testing a blood-based assay that looks at which types of chemotherapies will work best for each pancreatic cancer patient.
Chemotherapy Plus Stem Cell Infusion and Vitamins for BRCA Mutated Pancreatic Cancer
A clinical trial for pancreatic cancer patients with a BRCA mutation uses a combination of chemotherapy, vitamins, and stem cells.
PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations
A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.
Drug Onivyde Gives New Hope to Patients with Advanced Pancreatic Cancer
Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.
Targeting the Oxidation Pathway to Treat Advanced Pancreatic Cancer
Researchers are testing a new drug that targets the oxidation pathway in order to make standard chemotherapy more effective for stage IV pancreatic cancer.
The Alien Inside Me
Kim Vernick details the clinical trial and surgery used to treat her pancreatic cancer. When the cancer returns she explains the treatment she got.
Combining Immunotherapy and Targeted Therapy for Pancreatic Cancer
Researchers are combining immunotherapy and targeted therapy in a clinical trial for pancreatic cancer patients on platinum-based chemotherapy.
An Immunotherapy Game Changer
Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.